University of Missouri research reactor announced commercial shipments of radioisotope for cancer treatment
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
On Dec. 6, 2023, the federal government announced it had expanded the Home Test to Treat program, an…
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhaltaï¾® (iptacopan)…
On Dec. 4 2023, the University of Wisconsin-Madison researchers announced that while analyzing data from wastewater samples collected…
On Dec. 3, 2023, the Bill & Melinda Gates Foundation announced that global donors at COP28 had pledged…
On Dec. 1, 2023, the World Health Organization (WHO) announced that the International Health Regulations National Focal Point…
On Nov. 30, 2023, the U.S. Department of Department of Agricultureï¾’s (USDA) Animal and Plant Health Inspection Service…
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
On Nov. 30, 2023, researchers at Tufts University announced they had created tiny biological robots that they call…
On Nov. 30, 2023, researchers at Hokkaido University, in collaboration with colleagues at Woods Hole Oceanographic Institution announced…
On Nov. 29, 2023, Novavax’s partner, SK bioscience, announced that Novavax’s updated COVID-19 vaccine (NVX-CoV2601) had received Emergency…
On Nov. 29, 2023, the World Health Organization (WHO) announced that between 24 and 25 November 2023, the…
On Nov. 29, 2023, the BC Centre for Disease Controlr Disease Control (BCCDC) announced that a A passenger…
On Nov. 28, 2023, Novavax announced that Nuvaxovidï¾™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
On Nov. 28, 2023, Emergent BioSolutions announced that the Biomedical Advanced Research and Development Authority (BARDA) within the…
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
On Nov. 27, 2023, the U.S. Food and Drug Administration approved SpringWorks’ Ogsiveo (nirogacestat) tablets for adult patients…
On Nov. 27, 2023, the CDCï¾’s Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…
On Nov. 27, 2023, University of Wisconsin-Madison researchers released a study that showed COVID-19 caused an alarming surge…
On Nov. 23, 2023, Vertex announced that the European Medicines Agency (EMA) had validated a Type II variation…
On Nov. 23, 2023, the World Health Organization (WHO) announced that it was monitoring data from Chinese surveillance…
On Nov. 22, 2023, the U.S. Food and Drug Administration issued the final guidance COVID-19: Developing Drugs and…
On Nov. 21, 2023, the World Health Organization (WHO) reported that the BA.2.86 variant had been reported in…
On Nov. 17, 2023, the Oregon Department of Agriculture reported that the United States Department of Agricultureï¾’s National…
On Nov. 17, 2023, Masimo announced that the Masimo W1 medical watch has received FDA 510(k) clearance for…
On Nov. 17, 2023, the U.S. Department of Agriculture’s (USDA) announced the National Strategic Germplasm and Cultivar Collection…
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
On Nov. 16, 2023, the CDC announced the release of more than 77,000 additional doses of Beyfortusï¾™ (nirsevimab-alip…
On Nov. 16. 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Following years of…